世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000034001

耳鼻咽喉科疾患治療の世界市場規模調査・予測:薬剤タイプ別、臓器別、エンドユーザー別、地域別の分析(2022年〜2029年)

Bizwit Research & Consulting LLP

Global ENT Disorder Treatment Market Size study & Forecast, by Drug Type (Antibiotics Drugs, Anti Inflammatory Drugs, Others), by Organ (Throat, Ear, Nose), by End User (Hospital and clinics, Homecare Settings, Others) and Regional Analysis, 2022-2029

発刊日 2022/12/19

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000034001

Single
Enterprise (Global Site)

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

耳鼻咽喉科疾患治療の世界市場は、2021年に約24億米ドルと評価され、予測期間の2022年から2029年には6.5%を超える健全な成長率で成長すると予測されています。

耳鼻咽喉科疾患は、細菌やウイルスによって引き起こされる耳、鼻、喉に関連する感染症を指します。耳の感染症は、難聴、耳痛、耳漏などの原因となります。一方、鼻・喉の疾患は、喉の痛み、鼻水、いびき、睡眠時無呼吸症候群、呼吸困難などを引き起こす可能性があります。耳鼻咽喉科疾患には、抗生物質、抗炎症剤など、さまざまな治療法があります。高齢者の増加や感染症の流行、大手企業の戦略的な取り組みなどが、市場の成長を加速させる主な要因となっています。

世界保健機関(WHO)によると、2019年に世界的に約260万人が下気道感染症により命を落としています。さらに、オーストラリア保健福祉研究所の推計によると、2020年から2021年の会計年度に、オーストラリアでは324,000人以上の感染症による入院があり、そのうち約94%は届出対象外疾病でした。また、世界の汚染レベルの上昇と発展途上地域での医療費の増加は、予測期間中に市場に有利な成長見通しを生み出すでしょう。しかし、医療機器の高コストが、2022年から2029年の予測期間を通じて市場成長を阻害します。

耳鼻咽喉科疾患治療の世界市場の調査対象地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域です。北アメリカは、有力な市場プレイヤーの存在や、同地域における感染症の流行拡大などの要因から、市場シェアの面で主要な地域となっています。一方、アジア太平洋地域は、高齢者人口の増加や呼吸器疾患の増加などの要因により、予測期間中に大きく成長すると予想されています。

調査範囲

  • 調査企業
    ➣ Sanofi
    ➣ Novartis
    ➣ GSK
    ➣ Pfizer
    ➣ Vitaris
    ➣ Sun Pharma
    ➣ AstraZeneca
    ➣ Cipla
    ➣ AurbindoPharma
    ➣ Teva Pharmaceuticals
  • 調査対象年
    ➣ 実績データ - 2019年、2020年、2021年
    ➣ 基準年 - 2021年
    ➣ 予測期間 - 2022年から2029年

本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。

さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

  • 市場セグメント・サブセグメント
    ➣ 薬剤タイプ別
      ◇ 抗生物質医薬品
      ◇ 抗炎症薬
      ◇ その他
    ➣ 臓器別
      ◇ 喉
      ◇ 耳
      ◇ 鼻
    ➣ エンドユーザー別
      ◇ 病院・クリニック
      ◇ 在宅医療現場
      ◇ その他
    ➣ 地域別
      ◇ 北アメリカ
       ✓ アメリカ
       ✓ カナダ
      ◇ ヨーロッパ
       ✓ イギリス
       ✓ ドイツ
       ✓ フランス
       ✓ スペイン
       ✓ イタリア
       ✓ その他のヨーロッパ
      ◇ アジア太平洋地域
       ✓ 中国
       ✓ インド
       ✓ 日本
       ✓ オーストラリア
       ✓ 韓国
       ✓ その他のAPAC
      ◇ ラテンアメリカ
       ✓ ブラジル
       ✓ メキシコ
       ✓ 世界のその他の地域

レポート詳細

目次

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. ENT Disorder Treatment Market, by Region, 2019-2029 (USD Billion)
1.2.2. ENT Disorder Treatment Market, by Drug Type, 2019-2029 (USD Billion)
1.2.3. ENT Disorder Treatment Market, by Organ, 2019-2029 (USD Billion)
1.2.4. ENT Disorder Treatment Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global ENT Disorder Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global ENT Disorder Treatment Market Dynamics
3.1. ENT Disorder Treatment Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing number of geriatric individuals.
3.1.1.2. Growing prevalence of infectious diseases.
3.1.1.3. Strategic initiatives from leading market players.
3.1.2. Market Challenges
3.1.2.1. High cost associated with medical devices.
3.1.3. Market Opportunities
3.1.3.1. Growing pollution levels worldwide.
3.1.3.2. Rising healthcare spending in developing regions.

Chapter 4. Global ENT Disorder Treatment Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global ENT Disorder Treatment Market, by Drug Type
6.1. Market Snapshot
6.2. Global ENT Disorder Treatment Market by Drug Type, Performance - Potential Analysis
6.3. Global ENT Disorder Treatment Market Estimates & Forecasts by Drug Type 2019-2029 (USD Billion)
6.4. ENT Disorder Treatment Market, Sub Segment Analysis
6.4.1. Antibiotics Drugs
6.4.2. Anti-Inflammatory Drugs
6.4.3. Others

Chapter 7. Global ENT Disorder Treatment Market, by Organ
7.1. Market Snapshot
7.2. Global ENT Disorder Treatment Market by Organ, Performance - Potential Analysis
7.3. Global ENT Disorder Treatment Market Estimates & Forecasts by Organ 2019-2029 (USD Billion)
7.4. ENT Disorder Treatment Market, Sub Segment Analysis
7.4.1. Throat
7.4.2. Ear
7.4.3. Nose

Chapter 8. Global ENT Disorder Treatment Market, by End User
8.1. Market Snapshot
8.2. Global ENT Disorder Treatment Market by End User, Performance - Potential Analysis
8.3. Global ENT Disorder Treatment Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
8.4. ENT Disorder Treatment Market, Sub Segment Analysis
8.4.1. Hospital and clinics
8.4.2. Homecare Settings
8.4.3. Other

Chapter 9. Global ENT Disorder Treatment Market, Regional Analysis
9.1. ENT Disorder Treatment Market, Regional Market Snapshot
9.2. North America ENT Disorder Treatment Market
9.2.1. U.S. ENT Disorder Treatment Market
9.2.1.1. Drug Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Organ breakdown estimates & forecasts, 2019-2029
9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada ENT Disorder Treatment Market
9.3. Europe ENT Disorder Treatment Market Snapshot
9.3.1. U.K. ENT Disorder Treatment Market
9.3.2. Germany ENT Disorder Treatment Market
9.3.3. France ENT Disorder Treatment Market
9.3.4. Spain ENT Disorder Treatment Market
9.3.5. Italy ENT Disorder Treatment Market
9.3.6. Rest of Europe ENT Disorder Treatment Market
9.4. Asia-Pacific ENT Disorder Treatment Market Snapshot
9.4.1. China ENT Disorder Treatment Market
9.4.2. India ENT Disorder Treatment Market
9.4.3. Japan ENT Disorder Treatment Market
9.4.4. Australia ENT Disorder Treatment Market
9.4.5. South Korea ENT Disorder Treatment Market
9.4.6. Rest of Asia Pacific ENT Disorder Treatment Market
9.5. Latin America ENT Disorder Treatment Market Snapshot
9.5.1. Brazil ENT Disorder Treatment Market
9.5.2. Mexico ENT Disorder Treatment Market
9.6. Rest of The World ENT Disorder Treatment Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Sanofi
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Novartis
10.2.3. GSK
10.2.4. Pfizer
10.2.5. Vitaris
10.2.6. Sun Pharma
10.2.7. AstraZeneca
10.2.8. Cipla
10.2.9. AurbindoPharma
10.2.10. Teva Pharmaceuticals

Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

LIST OF TABLES
TABLE 1. Global ENT Disorder Treatment Market, report scope
TABLE 2. Global ENT Disorder Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global ENT Disorder Treatment Market estimates & forecasts by Drug Type 2019-2029 (USD Billion)
TABLE 4. Global ENT Disorder Treatment Market estimates & forecasts by Organ 2019-2029 (USD Billion)
TABLE 5. Global ENT Disorder Treatment Market estimates & forecasts by End User 2019-2029 (USD Billion)
TABLE 6. Global ENT Disorder Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global ENT Disorder Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global ENT Disorder Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global ENT Disorder Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global ENT Disorder Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global ENT Disorder Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global ENT Disorder Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global ENT Disorder Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global ENT Disorder Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global ENT Disorder Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row ENT Disorder Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row ENT Disorder Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global ENT Disorder Treatment Market
TABLE 71. List of primary sources, used in the study of global ENT Disorder Treatment Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES
FIG 1. Global ENT Disorder Treatment Market, research methodology
FIG 2. Global ENT Disorder Treatment Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global ENT Disorder Treatment Market, key trends 2021
FIG 5. Global ENT Disorder Treatment Market, growth prospects 2022-2029
FIG 6. Global ENT Disorder Treatment Market, porters 5 force model
FIG 7. Global ENT Disorder Treatment Market, pest analysis
FIG 8. Global ENT Disorder Treatment Market, value chain analysis
FIG 9. Global ENT Disorder Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global ENT Disorder Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global ENT Disorder Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global ENT Disorder Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global ENT Disorder Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global ENT Disorder Treatment Market, regional snapshot 2019 & 2029
FIG 15. North America ENT Disorder Treatment Market 2019 & 2029 (USD Billion)
FIG 16. Europe ENT Disorder Treatment Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific ENT Disorder Treatment Market 2019 & 2029 (USD Billion)
FIG 18. Latin America ENT Disorder Treatment Market 2019 & 2029 (USD Billion)
FIG 19. Global ENT Disorder Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

この商品のレポートナンバー

0000034001

TOP